![Thomas Biancardi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Biancardi
No más puestos en curso
Historial de carrera de Thomas Biancardi
Antiguos cargos conocidos de Thomas Biancardi.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - | - |
IVERIC BIO, INC. | Director de Operaciones | 01/09/2007 | 31/01/2012 |
Contacto de Relaciones con Inversores | 29/08/2013 | 14/01/2015 | |
Public Communications Contact | 01/09/2007 | - | |
Corporate Officer/Principal | 19/08/2013 | - | |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Director de Operaciones | - | - |
Director Financiero/CFO | - | - |
Formación de Thomas Biancardi.
New York University | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PFIZER, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
IVERIC bio, Inc.
![]() IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Biancardi
- Experiencia